United States · Series B startup
5 rounds we have observed, with the 5 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$62Mraised across 5 rounds since 2012, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
From a historical funding record
No investor was named in the report.
From a historical funding recordSEC filing: $1000K sold, first sale Feb 2014
From a historical funding recordSEC filing: $21M sold, first sale Dec 2012
Reported by finance.yahoo.comSEC filing: $16M sold, first sale Dec 2012
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
New Enterprise Associates
Nano DimensionFlagship Pioneering, LLCFlagship Ventures
Handshake VenturesMissing a round, or an investor who was in one? Tell us.
Blend Therapeutics's investors include New Enterprise Associates, Nano Dimension, Flagship Pioneering, LLC, Flagship Ventures and Handshake Ventures.
Blend Therapeutics has raised $62M across 5 rounds since 2012.
Blend Therapeutics's most recent round was a Series B of $21M in Jan 2015.
Blend Therapeutics's largest round on record is $21M (Series B), in Dec 2013.
Blend Therapeutics's first round on record, in Jan 2012, was backed by New Enterprise Associates and Flagship Pioneering, LLC.
Blend Therapeutics's latest named round is a Series B, in Jan 2015.
Blend Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·